Nagasaka T
Acta Obstet Gynaecol Jpn. 1981 Jun;33(6):757-66.
The sex steroid hormone receptor levels of uterine cytosol were assayed in the course of experimental induction of endometrial carcinoma in rats. Effects of administration of various hormones on the receptor levels were examined with each histological pattern of endometrium. 1) The dissociation constants for E2 and R5020 bindings with uterine cytosol were almost fixed in spite of various histological patterns of endometrium. 2) The influence of administrated hormones on the receptor assay system could be neglected by the preincubation of uterine cytosol with DCC for five times. 3) By the administration of DES for six weeks, estrogen receptor levels were increased significantly in adenocarcinoma, while progesterone receptor levels did not show the tendency of decreasing. 4) By the administration of MPA combined with DES, estrogen receptor levels were not decreased significantly in both atypical adenomatous hyperplasia and adenocarcinoma; progesterone receptor levels were decreased in all groups. 5) By the administration of MPA, estrogen receptor levels were decreased significantly in adenocarcinoma. These data suggest that receptor levels can be controlled by the administration of sex hormones in the course of development of endometrial carcinoma.
在大鼠子宫内膜癌实验诱导过程中,对子宫胞浆中的性甾体激素受体水平进行了测定。针对子宫内膜的每种组织学模式,研究了各种激素给药对受体水平的影响。1)尽管子宫内膜存在各种组织学模式,但E2和R5020与子宫胞浆结合的解离常数几乎是固定的。2)通过将子宫胞浆与DCC预孵育五次,可以忽略给药激素对受体检测系统的影响。3)给予己烯雌酚六周后,腺癌中的雌激素受体水平显著升高,而孕激素受体水平未显示出下降趋势。4)给予甲羟孕酮联合己烯雌酚后,非典型腺瘤样增生和腺癌中的雌激素受体水平均未显著降低;所有组的孕激素受体水平均降低。5)给予甲羟孕酮后,腺癌中的雌激素受体水平显著降低。这些数据表明,在子宫内膜癌发生发展过程中,受体水平可通过性激素给药来控制。